Currently, one of the most significant and rapidly growing unmet medical challenges is the
treatment of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's …

The lack of effective treatments for neurodegenerative diseases (NDs) is an important
current concern. Lipid nanoparticles can deliver innovative combinations of active molecules …

Peptides and proteins have recently emerged as efficient therapeutic alternatives to
conventional therapies. Although they emerged a few decades back, extensive exploration …

Conspectus For the delivery of drugs, different nanosized drug carriers (eg, liposomes, lipid
nanoparticles, and micelles) have been developed in order to treat diseases that afflict …

Neuroinflammation is a key pathophysiological feature of stroke-associated brain injury. A
local innate immune response triggers neuroinflammation following a stroke via activating …

Brain diseases are the most devastating problem among the world's increasingly aging
population, and the number of patients with neurological diseases is expected to increase in …

We will be serving as the Guest Editor for this very interesting Special Issue on “Non-
Invasive Device-Mediated Drug Delivery to the Brain Across the Blood–Brain Barrier”. It is …

Peptides have become an indispensable tool in engineering of multifunctional nanostructure
platforms for biomedical applications such as targeted drug and gene delivery, imaging and …

Our previous studies demonstrated that L-octaarginine grafted onto hyaluronic acid via a
tetraglycine spacer significantly enhanced intranasal absorption of protein drugs with a …

Blood–brain barrier (BBB) peptide-shuttles (BBBpS) are able to translocate the BBB and
reach the brain. Despite the importance of brain targeting in pharmacology, BBBpS are …